Literature summary for 2.3.2.B12 extracted from

Chatterjee, A.; Upadhyay, S.; Chang, X.; Nagpal, J.K.; Trink, B.; Sidransky, D.
U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DELTANp63alpha (2008), Cell Cycle, 7, 1231-1237.

Search for more literature for 2.3.2.B12

Application

Application	Comment	Organism
medicine	DELTANp63alpha, dominant negative isoform of the p63 family and essential survival factor in head and neck squamous cell carcinoma, physically interacts with U-box-type E4 ubiquitin ligase UFD2a. UFD2a stabilizes DELTANp63alpha, and ubiquitylation of DELTANp63?alpha is attenuated by UFD2a both in the presence and absence of cisplatin. Ectopic expression of UFD2a increases the half-life of DELTANp63alpha in association with a significant enhancement of the repressive transcriptional activity of DELTANp63alpha. Downregulation of endogenous UFD2a by RNAi results in degradation of DELTANp63alpha	Homo sapiens

Cloned(Commentary)

Cloned (Comment)	Organism
expression in JHU-022 cell and H-1299 cell	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	O95155	-	-

Synonyms

Synonyms	Comment	Organism
Ufd2a	-	Homo sapiens

General Information

General Information	Comment	Organism
physiological function	DELTANp63alpha, dominant negative isoform of the p63 family, physically interacts with U-box-type E4 ubiquitin ligase UFD2a. UFD2a stabilizes DELTANp63alpha, and ubiquitylation of DELTANp63?alpha is attenuated by UFD2a both in the presence and absence of cisplatin. Ectopic expression of UFD2a increases the half-life of DELTA?Np63alpha in association with a significant enhancement of the repressive transcriptional activity of DELTANp63alpha. Downregulation of endogenous UFD2a by RNAi results in degradation of DELTANp63alpha	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)